Bartonella treatment depends almost entirely on which disease the bacterium is causing and how healthy your immune system is. A mild case of cat scratch disease in an otherwise healthy adult may clear on its own or respond to a five-day course of azithromycin, while Bartonella endocarditis demands months of combination antibiotics and sometimes heart valve surgery. Between those extremes sit a range of clinical presentations, each with its own regimen, timeline, and monitoring challenges that make Bartonella infections trickier to manage than their low profile might suggest.
Cat Scratch Disease in Healthy People
Cat scratch disease is by far the most common Bartonella infection, caused by B. henselae after a scratch or bite from an infected cat. In people with normal immune function, it usually shows up as a swollen, tender lymph node near the wound site, sometimes with low-grade fever and fatigue. The good news is that most cases resolve without antibiotics over a period of weeks to months, though the swollen nodes can linger and be uncomfortable.
If your doctor decides to treat, azithromycin is the go-to. A landmark randomized trial found that a five-day course of azithromycin produced a roughly 80 percent decrease in lymph node volume in half of the treated patients within the first 30 days, compared to only about 1 in 15 patients on placebo. After the first month, though, the resolution rates evened out between treated and untreated groups, meaning the antibiotic speeds up recovery rather than changing the ultimate outcome.1PubMed. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease In practice, this means azithromycin is most useful when the lymph node swelling is severe, painful, or cosmetically bothersome, rather than being strictly necessary for everyone.
A pediatric study found that while most children responded to five days of azithromycin, some needed an extended course of 10 to 14 days, and a handful required a switch to rifampicin with or without doxycycline when the initial treatment fell short.2PubMed Central. Clinical Presentation of Cat Scratch Disease in Pediatric Patients—A Single-Center Study Children under eight are generally given azithromycin rather than doxycycline because of longstanding concerns about tetracycline effects on developing teeth, though recent guidance has loosened that restriction for short courses in some settings.
When Bartonella Reaches the Heart
Bartonella endocarditis is the most dangerous manifestation and the one where treatment intensity ratchets up dramatically. Both B. henselae and B. quintana can infect heart valves, and Bartonella species collectively account for a meaningful share of “culture-negative” endocarditis cases, those where standard blood cultures come back empty but the patient is clearly sick. The bacterium’s ability to hide inside endothelial cells and erythrocytes makes it especially elusive in routine lab work.3PubMed. Molecular and cellular basis of bartonella pathogenesis
Treatment for Bartonella endocarditis requires prolonged combination therapy. The standard approach is doxycycline for four to six months, with an aminoglycoside like gentamicin added during the first two to three weeks.4Clinical Infectious Diseases. Bartonella quintana and Urban Trench Fever The aminoglycoside provides bactericidal punch early on, while the longer doxycycline course aims to clear intracellular reservoirs. Some protocols substitute a third-generation cephalosporin for gentamicin in that initial window. Valve replacement surgery is sometimes unavoidable if the infection has caused severe valve destruction, and outcomes tend to be worse when surgery is delayed.
The evidence base for this regimen comes partly from a randomized trial showing that doxycycline plus gentamicin eradicated B. quintana bacteremia in all seven patients who completed the protocol, compared to only about two in nine untreated controls.5PubMed Central. Randomized open trial of gentamicin and doxycycline for eradication of Bartonella quintana from blood in patients with chronic bacteremia The numbers are small, which reflects the rarity of Bartonella endocarditis, but the signal was strong enough to shape current recommendations.
Eye and Brain Involvement
Bartonella neuroretinitis, an inflammation of the optic nerve and retina, is one of the more alarming complications of cat scratch disease. It can cause sudden vision loss, and though it often improves on its own in healthy people, the risk of lasting visual damage makes treatment a reasonable choice. Doxycycline at 100 mg twice daily for two to four weeks is the standard regimen for adults and older children. In severe cases or when vision loss is significant, rifampin is sometimes added, and the course may stretch to four to six weeks.6PubMed Central. Update on Bartonella neuroretinitis7PubMed. Treatment Strategies for Neuroretinitis: Current Options and Emerging Therapies
One clinical consideration that sometimes catches doctors off guard is the drug interaction between rifampin and other medications. Rifampin is a potent inducer of liver enzymes, which means it speeds up the breakdown of many drugs in your body, including doxycycline and prednisone. A case-based study noted that rifampin can significantly reduce plasma levels of both doxycycline and steroids, potentially undermining the entire treatment plan when all three are used together.8PubMed. Treatment of Severe Neuroretinitis and other Sequelae Associated with Cat Scratch Disease Doxycycline monotherapy was found to be effective and well-tolerated in many neuroretinitis cases, suggesting that adding rifampin should be a deliberate decision rather than a reflexive one.
Immunocompromised patients with neuroretinitis face a much longer road. A prolonged course of up to four months may be required, reflecting how much harder it is to clear Bartonella when the immune system isn’t providing backup.6PubMed Central. Update on Bartonella neuroretinitis
Treatment for Immunocompromised Patients
When someone with HIV, an organ transplant, or another cause of immune suppression gets infected with Bartonella, the stakes change considerably. These patients are susceptible to bacillary angiomatosis, a condition where the bacteria stimulate abnormal blood vessel growth, producing reddish-purple skin lesions that can look disturbingly similar to Kaposi sarcoma. Bartonella achieves this by hijacking endothelial cells, suppressing normal cell death, and stimulating cell proliferation, effectively turning the body’s vasculature into a growth medium.3PubMed. Molecular and cellular basis of bartonella pathogenesis
Doxycycline is again the backbone of treatment, but the duration is substantially longer than for cat scratch disease. A reported case of an HIV-infected child with bacillary angiomatosis showed complete resolution of skin lesions after a three-month course of oral doxycycline (100 mg twice daily), with no recurrence afterward.9PubMed Central. Successful treatment of bacillary angiomatosis with oral doxycycline in an HIV-infected child with skin lesions mimicking Kaposi sarcoma Three months is a common minimum for bacillary angiomatosis, and some experts recommend continuing antibiotics until the immune system has been adequately restored, for example through antiretroviral therapy in HIV patients.
Combination therapy with agents like rifampin or aminoglycosides is more frequently needed in this population because treatment failures with single-drug regimens are more common. A major treatment review emphasized that prolonged administration of cell wall-active agents combined with aminoglycosides or rifampin is frequently required for severe or chronic Bartonella disease in immunocompromised people.10PubMed Central. Recommendations for treatment of human infections caused by Bartonella species Relapse rates are higher in this group even with appropriate therapy, so close follow-up is essential.
Trench Fever and B. quintana Infections
B. quintana, the species behind trench fever, is transmitted by body lice and remains a real concern among people experiencing homelessness and in crowded, unsanitary conditions. Unlike cat scratch disease, B. quintana tends to produce relapsing bacteremia, meaning the bacteria cycle through the bloodstream in waves that can persist for weeks or months without treatment.
For uncomplicated B. quintana bacteremia, experts recommend doxycycline, erythromycin, or azithromycin for four to six weeks.4Clinical Infectious Diseases. Bartonella quintana and Urban Trench Fever Endocarditis caused by B. quintana requires a much longer course of four to six months, with an aminoglycoside or third-generation cephalosporin added for the first two to three weeks. A study of homeless individuals with chronic B. quintana bacteremia confirmed that the gentamicin-plus-doxycycline combination was effective at preventing relapses.11Clinical Infectious Diseases. Bartonella quintana Bacteremia among Homeless People
The relapsing nature of B. quintana infection is partly explained by the bacterium’s life cycle. After entering red blood cells, Bartonella replicates to a static level of roughly eight organisms per cell, at which point the infected red blood cells become indistinguishable from normal ones and escape immune clearance.12Frontiers in Cellular and Infection Microbiology. Molecular Mechanisms of Bartonella and Mammalian Erythrocyte Interactions: A Review – Section: Erythrocyte Replication and Persistence This stealth phase inside red blood cells is one reason antibiotics need to be maintained long enough for the immune system and the drugs together to catch circulating organisms across multiple replication cycles.
Monitoring Treatment Response
One of the frustrations of Bartonella treatment is the lack of clear guidelines for monitoring whether antibiotics are actually working. Standard Bartonella serology, which measures antibody levels, has well-known limitations. Antibody titers can remain elevated for months or even years after a resolved infection, making it difficult to distinguish active disease from immunological memory. Conversely, immunocompromised patients sometimes fail to mount a detectable antibody response at all.
Molecular testing using PCR (which detects the bacterium’s DNA directly) offers a more real-time picture of whether the organism is still present. A case series evaluating species-specific real-time PCR for treatment monitoring found that it played a useful role both in initial diagnosis and in gauging whether therapy was working. The researchers also noted a discrepancy between PCR and serology results, with the PCR providing more actionable information about active infection status.13PubMed Central. Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series The practical takeaway is that falling or negative PCR results are a more reliable signal that treatment is clearing the infection than falling antibody titers, though PCR availability remains limited outside specialized laboratories.
For cat scratch disease that is clearly improving clinically, most doctors rely on physical examination and symptom resolution rather than repeated lab testing. But for endocarditis, bacillary angiomatosis, or chronic bacteremia, serial monitoring becomes much more important. Echocardiography tracks valve function in endocarditis, and repeat imaging may be needed for months. The absence of standardized monitoring protocols means clinicians often have to rely on clinical judgment, watching for fever resolution, improvement in lesions, normalization of inflammatory markers, and eventually clearance of the organism by PCR when available.
Why Bartonella Can Be Difficult to Eradicate
Bartonella species have several biological traits that make them harder to kill than their relatively simple bacterial structure would suggest. Beyond hiding inside red blood cells, they colonize endothelial cells lining blood vessels, a niche that many antibiotics penetrate poorly.3PubMed. Molecular and cellular basis of bartonella pathogenesis B. bacilliformis infection has also been shown to trigger overproduction of the anti-inflammatory cytokine IL-10, which dampens the immune response and may contribute to chronic, asymptomatic carriage, meaning some infected individuals become silent reservoirs without knowing it.14PLOS Neglected Tropical Diseases. Immunosuppressive and angiogenic cytokine profile associated with Bartonella bacilliformis infection in post-outbreak and endemic areas of Carrion’s disease in Peru
Laboratory research has also uncovered that B. henselae can form stationary-phase “persister” populations and biofilms, both of which are far more tolerant of antibiotics than actively dividing bacteria. An in vitro study tested 14 antibiotics and 25 combinations against these drug-tolerant forms. Ciprofloxacin, gentamicin, and nitrofurantoin were the most active single agents against stationary-phase bacteria. More striking, certain two-drug combinations killed stationary-phase B. henselae completely within a single day of exposure. Azithromycin combined with ciprofloxacin, and rifampin combined with ciprofloxacin, both achieved undetectable bacterial counts after just 24 hours. For biofilm-encased bacteria, methylene blue and rifampin stood out, and combinations including these drugs eradicated biofilm B. henselae after six days of treatment.15PubMed Central. Effect of different drugs and drug combinations on killing stationary phase and biofilms recovered cells of Bartonella henselae in vitro
This research is still in the lab, not the clinic, so it would be premature to change treatment based on it. But it helps explain why some patients relapse after seemingly adequate courses of antibiotics, particularly those with deep-seated or chronic infections. It also opens doors for future regimens that specifically target persister populations, potentially shortening treatment times or reducing relapse rates once clinical trials catch up.
Coinfections and Their Impact on Treatment
Bartonella does not always arrive alone. Tick-borne coinfections are an increasingly recognized complication, particularly in patients who also carry Borrelia burgdorferi (the Lyme disease agent) or Babesia species. These organisms can be transmitted by the same tick bite or acquired independently, and their overlap can create a clinical picture that is messier and harder to treat than any single infection.16PubMed Central. Chronic Lyme Disease and Co-infections: Differential Diagnosis
When symptoms persist despite treatment for one organism, coinfection should be on the radar. A case series described three patients with relapsing borreliosis, babesiosis, and bartonellosis who continued to cycle through symptoms despite extended courses of standard anti-infective therapy. The authors emphasized that identifying and treating all active coinfections was critical for achieving long-term remission.17PubMed Central. Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review The practical message is straightforward: if you are being treated for a tick-borne illness and not getting better, it is worth testing for additional pathogens rather than simply extending the same antibiotic.
Differentiating Bartonella symptoms from those of Lyme disease can be genuinely difficult. Both can cause fatigue, joint pain, neurological symptoms, and a general sense of feeling unwell. Bartonella is more classically associated with lymph node swelling and vascular lesions, while Lyme tends to feature the characteristic erythema migrans rash and joint inflammation, but atypical presentations blur these lines constantly.
Preventing Reinfection Through Flea and Louse Control
Treatment means little if the source of infection is still active in the household. For B. henselae, the primary reservoir is domestic cats, and the primary vector is the cat flea. Cats themselves are usually asymptomatic carriers, which means the household cat that gave you cat scratch disease looks perfectly healthy and will continue to harbor the bacteria unless flea transmission is interrupted.
A study of privately owned cats tested whether a sustained-release flea collar containing imidacloprid and flumethrin could reduce the risk of Bartonella infection. Based on the yearly incidence, the collar achieved a preventive efficacy of about 72 percent. Flea-infested cats were roughly three times more likely to be infected with Bartonella than uninfested cats.18PubMed Central. Effectiveness of a 10% imidacloprid/4.5% flumethrin polymer matrix collar in reducing the risk of Bartonella spp. infection in privately owned cats Consistent flea control on all household cats is the single most effective step you can take to reduce reinfection risk, especially if you are immunocompromised or have had a previous Bartonella infection.
For B. quintana, the vector is the body louse, and prevention centers on hygiene, access to laundered clothing, and louse treatment. This is primarily a public health challenge rather than an individual one, since B. quintana transmission clusters among populations with limited access to bathing and clean clothing. Outreach programs that provide laundry services and insecticide-treated clothing have been used in some settings to reduce transmission, though the evidence base is less developed than for flea control in cats.